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ABSTRACT
A number of benzo-fused oxygen-containing heterocycles were synthesized from allyl-3-isopropoxy-4-methoxybenzaldehyde
using metathesis or an alkene isomerization-metathesis sequence as key synthetic steps. Benzo-fused compounds thus formed
included a 3,6-dihydro-1H-2-benzoxocine, 1,3-dihydro-benzo[c]oxepine, 1H-isochromene, 2,3-dihydro-benzo[b]oxepine,
benzofuran and 2H-chromene skeleton, demonstrating the versatility of this methodology.
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1. Introduction
There are many examples of benzo-fused oxygen-containing
heterocycles described in the chemical literature. Examples of 5-,
6-, 7- and 8-membered oxygen-containing benzo-fused rings
include the 1- and 2-benzoxepine 1 and 2, the chromane 3, the
isochromene 4, the 1-benzofuran 5 and the 2-benzoxocine 6
skeletons (Fig. 1).
Benzo-fused naturally-occurring products with an oxygen
atom in the 1-position and unsaturation in the hetero-
aromatic ring are known and some representative examples are
shown in Fig. 2. Cnidioside B 7, a substituted 1-benzofuran iso-
lated from the aerial parts of the plant Ruta graveolens, was found
to possess antimicrobial and cytotoxic activities.1 Dalbergi-
chromene 8 with a 2H-chromene skeleton was isolated from the
stem bark and heartwood of the timber tree Dalbergia sissoo.2
Finally, the 1-benzoxepine class of compounds is represented by
radulanin L 9, an interesting bibenzyl isolated from Radula
complanata.3
On the other hand, unsaturated naturally-occurring benzo-
fused compounds with the oxygen atom in the 2-position are
much more scarce and seem to only occur in more highly
oxidized forms; e.g. drypemolundein A 10 isolated from the
Cameroonian plant Drypetes molunduana.4 Of interest is that this
compound also contains the 1-benzofuran skeleton.
Benzo-fused oxygen-containing heterocycles have also been
frequently used as pharmaceutical templates and four examples
are highlighted in Fig. 3. An SAR investigation showed that the
2-methyl-1-benzofuran, as shown for general compound 11,
was a critical binding element for a range of orally active FXa
inhibitors.5 2H-chromen-7-yl sulfamate 12 was synthesized as a
potential inhibitor of the enzyme steroid sulfatase and is thus
important for the treatment of hormone-dependent tumours,
e.g. of the breast.6 Another example in this series is the
1H-isochromene compound 13 synthesized by Wünsch and
co-workers7 in their studies of tricyclic amine compounds with
potential CNS activity. This research group has also synthesized
other substituted 1H-isochromene derivatives in their investiga-
tions.8 Finally a lobatamide C analogue 14, with a large lactone
ring, was synthesized as an analogue of the naturally occurring
compound and tested for V-ATPase inhibition.9
It should therefore not be surprising that there are many
published methods for the generation of these types of benzo-
fused structural units. One of these potential approaches is by
way of ring-closing metathesis (RCM). RCM is a very useful reac-
tion and this methodology needs little introduction.10 However,
the use of base- or metal-mediated isomerization reactions to
generate precursors with the alkenes in the required positions
for metathesis has only seen modest application in synthesis.
This phenomenon of pre- or post-metathesis isomerization is,
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Figure 1
Figure 2
however, very useful and its occurrence in the literature has
been high-lighted in recent reviews and accounts by Schmidt.11
Our group12a–h and others13 have made extensive use of
isomerization, followed by ruthenium-mediated metathesis, to
synthesize a range of benzo-fused compounds.12i
In this paper we aim to demonstrate the power of alkene
isomerization reactions coupled to the use of RCM reactions by
generating examples of the O-containing benzo-fused com-
pounds 1–6, of different ring sizes, from the same precursor 15.14
This compound has been extensively used in our work before as
a scaffold for the formation of other benzo-fused compounds.15
The organometallic catalysts that we used in this study were the
ruthenium based Grubb’s second-generation catalyst 16 and the
isomerization catalyst 17.16
2. Results and Discussion
The initial synthetic work focused on the synthesis of the
8-membered 3,6-dihydro-1H-2-benzoxocine skeleton, commu-
nicated earlier.12a To this end compound 15 was converted into
the bis-allyl precursor 19 by initial reduction of the aldehyde
group with lithium aluminum hydride to afford the substituted
benzyl alcohol 18. This reaction was followed by an allylation of
the primary alcohol to give the desired compound 19. The subse-
quent metathesis reaction on this substrate afforded the desired
1H-2-benzoxocine 20 in a moderate yield of 52%. The 1H NMR
spectrum of compound 20 depicted the alkene peaks of the
heterocyclic ring as multiplets at δ 5.54–5.61 and 5.82–5.91 and
the HRMS molecular ion for the compound, 248.1413, compared
well with the calculated value for C15H20O3: 248.1412. Finally,
confirmation of the structure of 20 was provided by comparison
of our NMR data with data for a number of other 3,6-dihydro-
1H-2-benzoxocines generated by metathesis.17
To synthesize the 7-membered 1,3-dihydro-2-benzoxepine
ring system 22, we needed to access a precursor that contained a
styrene functionality rather than the allyl found at C-2 of com-
pound 19. Therefore we attempted to isomerize the allyl group
of compound 19 with [RuClH(CO)(PPh3)3] 17 but this led to mix-
tures of desired product 21 and a partially characterized
benzaldehyde, probably formed by the deallylation of the
benzyl alcohol followed by oxidation. As a satisfactory solution
to this problem we found that treatment of the bis-allyl com-
pound 19 with potassium t-butoxide, under very mild condi-
tions, resulted in the formation of product 21. Inspection of the
NMR spectra of this compound proved that 21 was a mixture of
E,Z-isomers and it was clear that a selective isomerization to
afford the styrene had occurred. To the best of our knowledge,
this type of selective isomerization process with potassium
t-butoxide is not well known12d and confirmation of precisely
which allyl group had isomerized was readily provided by NMR
spectroscopy. It was clear, from the respective 1H NMR spectra,
that the ArCH2 peak (a multiplet at ~δ 3.5 in the spectrum of 19)
had disappeared while the OCH2 peak (a multiplet at ~δ 4.0)
was still evident in both the 1H NMR spectra of compounds 19
and 21. Furthermore, the ArCH2 peak in the
13C NMR spectrum
of 19 (δ 30.6) had been replaced in the corresponding spectrum
of 21 by a peak for the newly formed methyl group at δ 19.2.
Gratifyingly, when compound 21 was subjected to metathesis
it afforded 1,3-dihydro-6-isopropoxy-7-methoxy-2-benzoxepine
22 in an acceptable yield (64%) along with some unreacted start-
ing material 21 (28%). Confirmation of the structure of 22
was once again supplied by NMR spectroscopy. The proposed
position of the alkene, conjugated to the aromatic ring, was
supported by the 13C NMR spectrum as the only methylene
signals occurred at δ 72.8 and 73.0, indicating that both were
adjacent to the ring oxygen atom. Finally, the HRMS for com-
pound 22 (calculated for C14H18O3: 234.1256, found: 234.1256)
confirmed that a metathetic cyclization had occurred on sub-
strate 21. A point to note is that this example represents the first
use of metathesis to form the 2-benzoxepine skeleton.
Finally we also decided to synthesize the oxygen-containing
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Reagents and conditions: (a) LiAlH4, THF, 0°C, N2, 12 h, 86%; (b) allyl bro-
mide, NaH, THF, reflux, N2, 20 h, 77%; (c) 16 (5 mol %), toluene, 60°C, N2,
2 h, 52%.
Scheme 2
Reagents and conditions: (a) KOBut, DMF, r.t., N2, 16 h, quantitative;
(b) 16 (5 mol %), toluene, 80°C, N2, 2 h, 64% and recovered 21 28%.
heterocycle 24 by way of a bis-isomerization-RCM strategy.12a
When compound 19 was reacted with catalyst 17 (0.5 mol %) the
formation of compound 23 was monitored by TLC and 1H NMR
spectroscopy on crude aliquots of the reaction mixture. When
the isomerization process was considered complete, Grubb’s
second-generation catalyst 16 was added to 23 and the
1H-isochromene 24 was isolated in a good yield of 83% over two
steps after chromatographic purification. In the 1H NMR spec-
trum of 24 the two alkene peaks were evident as doublets (J =
5.8 Hz) at δ 6.10 and 6.58 and the methylene peak was present as
a singlet at δ 4.95. The HRMS spectrum confirmed that a
cyclization had taken place to afford 1H-isochromene 24 (calcu-
lated for C13H16O3: 220.1099, found: 220.1098). Once again, this
methodology, involving a bis-isomerization followed by a
metathesis reaction, is novel in its application to the synthesis of
the 1H-isochromene skeleton.12a
Next we decided to modify substrate 15 by performing a
Bayer-Villiger oxidation and subsequent hydrolysis to form
phenol 25; in effect removing a methylene fragment from sub-
strate 18 previously used in our study. Reaction of 15 with acidic
H2O2 resulted in a good yield of 25 after purification by chroma-
tography.18 The intermediate ester is assumed to have under-
gone hydrolysis during the purification step. This compound
was then subjected to our standard allylation conditions (allyl
bromide, potassium carbonate, acetone, reflux) to afford the
bis-allyl system 26. Once again this substrate readily gave the
7-membered unsaturated 2,5-dihydro-1-benzoxepine system 27
in excellent yield under our standard metathesis conditions. The
HRMS molecular ion for this compound, 234.1266, compared
well the calculated value for C14H18O3: 234.1256 and the NMR
spectra corresponded to the data published for similar
2,5-dihydro-1-benzoxepines in the literature.18,19
This same bis-allyl 26 substrate was also exposed to the
isomerization catalyst 17 which led to the facile isomerization of
both alkenes to the more thermodynamically stable compound
28 as a mixture of E- and Z-alkenes. Treatment of this substrate
with Grubb’s II catalyst 16 afforded the substituted benzofuran
29 in an analogous manner to previous work published by us.12f
Of interest is that this compound has been synthesized before
albeit using different methodology to insert the vinyloxy group20
and the spectral data generated for compound 29 compared well
with that published in the literature.
Finally we wished to extend our methodology to synthesize
the corresponding 2H-chromene from the precursor 25, in a
similar manner to what we have published before for chromene
systems.12g Firstly we attempted a selective isomerization on
bis-allyl compound 26 but were unable to find the conditions to
successfully achieve this reaction. We were thus forced to change
our strategy and fortunately the isomerization of 25 occurred
without mishap resulting in the formation of the desired styrene
30 in good yield. A standard O-allylation reaction21 then readily
afforded 31 which underwent a RCM reaction to afford
6-methoxy-5-isopropoxy-2H-chromene 32 in a moderate yield.22
The HRMS molecular ion for compound 32, 220.1101, compared
well with the calculated value for C13H16O3: 220.1099, confirming
that the metathesis reaction had successfully generated the
2H-chromene skeleton.
3. Conclusion
In this paper we have demonstrated the advantage of the
strategic application of metathesis and isomerization methodol-
ogies to synthesize oxygen-containing benzo-fused com-
pounds: 1H-2-benzoxocine 20, 2-benzoxepine 22, 1H-iso-
chromene 24, 1-benzoxepine 27, 1-benzofuran 29 and
2H-chromene 32. All were synthesized from a common precur-
sor, the benzaldehyde 15, underlining the strength of this meth-
odology. We are presently using this synthetic approach towards
the syntheses of various naturally-occurring compounds and
their analogues.
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Scheme 3
Reagents and conditions: (a) 17 (0.5 mol %), toluene, 60°C, N2, 2 h, 52%;
(b) 16 (5 mol %), toluene, 60°C, N2, 2 h, 83% over two steps.
Scheme 4
Reagents and conditions: (a) H2O2, H2SO4, MeOH, 0°C → r.t., N2, 2 h,
93%; (b) allyl bromide, K2CO3, acetone, reflux, N2, 2 h, then r.t., 48 h, 97%;
(c) 16 (5 mol %), toluene, 60°C, N2, 13 h, 80%.
Scheme 5
Reagents and conditions: (a) 17 (0.5 mol %), toluene, 65°C, N2, 14 h, 99%;
(b) 16 (5 mol %), toluene, 60°C, N2, 14 h, 55%.
Scheme 6
Reagents and conditions: (a) 17 (5 mol %), toluene, 65°C, N2, 23 h, 93%;
(b) allyl bromide, K2CO3, acetone, reflux, Ar, 20 h, 75%; (c) 16 (5 mol %),
toluene, 60°C, N2, 2 h, 76%.
4. Experimental
1H NMR and 13C NMR spectra were recorded either on a
Bruker AC-200, Bruker 300 or Bruker DRX 400 spectrometer at
the frequency indicated. All 13C signals in the aromatic/alkene
region have been assigned as quaternary (C) or non-quaternary
(CH). Infrared spectra were recorded on either a Bruker IFS 25
Fourier Transform spectrometer or on a Bruker Vector 22 Fourier
Transform spectrometer. Mass spectra were recorded on a
Kratos MS 9/50, VG 70E MS or a VG 70 SEQ mass spectrometer.
Macherey-Nagel kieselgel 60 (particle size 0.063–0.200 mm) was
used for conventional silica gel chromatography. All solvents
used for reactions and chromatography were distilled prior to
use. In certain cases solvents were degassed by bubbling argon
gas through the solvent for 15 min.
(2-Allyl-3-isopropoxy-4-methoxyphenyl)methanol . 2-Allyl-
3-isopropoxy-4-methoxybenzaldehyde 15 (1.01 g, 4.32 mmol)
was dissolved in dry THF (30 cm3). The solution was cooled to
0°C before LiAlH4 (0.32 g, 8.5 mmol) was added slowly. The re-
sulting mixture was then heated to 40°C and stirred under a N2
atmosphere for 12 h. After that, the reaction mixture was
quenched with an aqueous hydrochloric acid solution (5%,
100 cm3). The aqueous layer was then extracted with Et2O (2 ×
30 cm3) followed by dry CH2Cl2 (2 × 30 cm
3). The organic layer
was then combined and dried (MgSO4). The residue was then
purified by silica gel column chromatography (20–30%
EtOAc-hexane) to afford the desired benzyl alcohol 18 as a clear
oil (0.868 g, 86%). νmax (film)/cm
–1 (NaCl plate) 3447 br, 2975, 1637,
1601, 1579, 1488, 1466, 1437, 1407, 1382, 1369 and 1345; 1H NMR
(300 MHz; CDCl3; Me4Si) 1.27 [6H, d, J = 6.2 Hz, CH(CH3)2], 2.06
(1H, s, OH), 3.55–3.57 (2H, m, ArCH2CHCH2), 3.82 (3H, s, OCH3),
4.51 [1H, sept, J = 6.2Hz, CH(CH3)2], 4.60 (2H, s, ArCH2OH),
4.91–5.02 (2H, m, CH2CHCH2), 5.93–6.04 (1H, m, CH2CHCH2),
6.77 (1H, d, J = 8.4Hz, 5-H) and 7.05 (1H, d, J = 8.4Hz, 6-H);
13C NMR (75 MHz; CDCl3) 22.6 [CH(CH3)2], 30.6 (ArCH2CHCH2),
55.6 (OCH3), 63.3 (ArCH2OH), 74.5 [CH(CH3)2], 110.1 (CH), 115.0
(CH), 123.9 (CH), 132.3 (CH), 137.7 (C), 137.8 (C), 145.1 (C) and
152.5 (C); MS m/z 236 (M+, 100%), 209 (24), 194 (71), 193 (61), 177




(0.25 g, 1.06 mmol) and allyl bromide (0.11 cm3, 1.3 mmol) were
dissolved in dry THF (20 cm3). NaH (60% in oil, 0.076 g, 3.2 mmol)
was then added to the clear solution. The reaction mixture was
heated under reflux for 20 h under a N2 atmosphere while stir-
ring. Workup was done by adding H2O (50 cm
3) and subsequent
extraction of the organic material with Et2O (3 × 30 cm
3). The
organic layer was combined, dried (MgSO4) and the solvent was
removed in vacuo. The residue was then purified by silica gel
column chromatography (20% EtOAc-hexane) to afford the
desired product 19 as a clear oil (0.225 g, 77%). νmax (film)/cm
–1
(NaCl plate) 1638, 1601, 1580, 1489, 1466, 1437 and 1381; 1H NMR
(300 MHz, CDCl3, assignments with same superscript may be
interchanged) 1.27 [6H, d, J = 6.2 Hz, CH(CH3)2], 3.52–3.54 (2H,
m, ArCH2CHCH2), 3.82 (3H, s, OCH3), 3.99–4.01 (2H, m,
OCH2CHCH2), 4.44 (2H, s, ArCH2O), 4.50 [1H, sept, J = 6.2Hz,
CH(CH3)2], 4.89–4.98 (2H, m, CH2CHCH2),
a 5.17–5.32 (2H, m,
OCH2CHCH2),
a 5.85–6.02 (2H, m, ArCH2CH=CH2 and
OCH2CH=CH2), 6.75 (1H, d, J = 8.4Hz, 5-H) and 7.04 (1H, d, J =
8.4Hz, 6-H); 13C NMR (75 MHz, CDCl3, assignments with same
superscript may be interchanged) 22.6 [CH(CH3)2], 30.6
(ArCH 2 CHCH 2 ), 55.6 (OCH 3 ) , 70.1 (ArCH 2 O),
b 71.1
(OCH2CH=CH2),
b 74.5 [CH(CH3)2], 109.8 (CH), 114.8 (CH), 117.0
(CH), 124.4 (CH), 129.6 (C), 132.9 (C), 135.0 (CH), 136.9 (CH),
145.1 (C) and 152.6 (C); MS m/z 276 (M+, 92%), 193 (15), 178 (52),
177 (85), 176 (100), 161 (59) and 145 (32); HRMS calculated for
C17H24O3: 276.1725, found: 276.1726.
7-Isopropoxy-8-methoxy-3,6-dihydro-1H-2-benzoxocine . To
a solution of 2-allyl-1-[(allyloxy)methyl]-3-isopropoxy-4-
methoxybenzene 19 (0.20 g, 0.72 mmol) in toluene (60 cm3), was
added Grubb’s catalyst 16 (5 mol %, 0.031 g, 0.04 mmol) and the
reaction mixture was stirred at 60°C for 2 h The solvent was then
removed under reduced pressure and the residue was purified
by silica gel chromatography (2–10% EtOAc-hexane) to give the
desired cyclized product 20 as a clear oil (0.092 g, 52%). νmax
(film)/cm–1 (NaCl plate) 1269, 1381, 1436, 1488, 1574 and 1598;
1H NMR (300 MHz, CDCl3, assignments with same superscript
may be interchanged) 1.21 [6H, d, J = 6.2 Hz, CH(CH3)2], 3.67 (2H,
d, J = 7.2 Hz, 6-H), 3.75 (3H, s, OCH3), 4.08 (2H, d, J = 4.9 Hz, 3-H),
4.35 [1H, sept, J = 6.2 Hz, CH(CH3)2], 4.73 (2H, s, 1-H), 5.54–5.61
(1H, m, 4-H),a 5.82–5.91 (1H, m, 5-H),a 6.64 (1H, d, J = 8.3 Hz, 9-H)
and 6.75 (1H, d, J = 8.3 Hz, 10-H); 13C NMR (75 MHz; CDCl3,
assignments with same superscript may be interchanged) 22.6
[CH(CH3)2], 25.9 (6-C), 55.7 (OCH3), 66.3 (3-C),
a 72.2 (1-C),a 74.8
[CH(CH3)2], 109.5 (CH), 123.7 (CH), 127.9 (CH), 130.1 (C), 131.7
(CH), 133.6 (C), 144.3 (C) and 152.8 (C); MS m/z 248 (M+, 100%),
206 (29), 177 (20), 175 (16), 161 (18), 143 (17) and 117 (12); HRMS
calculated for C15H20O3: 248.1412, found: 248.1413.
1-[(Allyloxy)methyl]-3-isopropoxy-4-methoxy-2-(1-propenyl)
benzene . 2-Allyl-1-[(allyloxy)methyl]-3-isopropoxy-4-
methoxybenzene 19 (0.10 g, 0.39 mmol) was dissolved in distilled
DMF (15 cm3). KOBut (0.044 g, 0.36 mmol) was added slowly to
the clear solution at r.t. The mixture was then stirred under a N2
atmosphere at r.t. for 16 h The reaction mixture was then
quenched with aqueous HCl (5%, 50 cm3), followed by extraction
of the aqueous layer with CH2Cl2 (3 × 30 cm
3). The organic layer
was separated, dried (MgSO4) and the solvent was removed
in vacuo. The residue was then purified by silica gel column
chromatography (10–20% EtOAc-hexane) to afford the desired
product 21 as a clear oil (0.099 g, quantitative, E:Z 5:1). νmax
(film)/cm–1 (NaCl plate) 1597, 1573, 1484, 1425 and 1381; 1H NMR
(300 MHz; CDCl3, only E-isomer listed) 1.24 [6H, d, J = 6.2 Hz,
CH(CH3)2], 1.90 (3H, dd, J = 6.6 and 1.6 Hz, CHCHCH3), 3.81 (3H,
s, OCH3), 4.01–4.04 (2H, m, OCH2CHCH2), 4.32 [1H, sept, J =
6.2 Hz, CH(CH3)2], 4.43 (2H, s, ArCH2O), 5.16–5.33 (2H, m,
CH2CHCH2), 5.90–6.01 (1H, m, CHCHCH3), 6.03–6.17 (1H, m,
CH2CHCH2), 6.48 (1H, dd, J = 16.0 and 1.6 Hz, CHCHCH3), 6.76
(1H, d, J = 8.4 Hz, 5-H) and 7.08 (1H, d, J = 8.4 Hz, 6-H); 13C NMR
(75 MHz; CDCl3, only E-isomer listed, assignments with same
superscript may be interchanged) 19.2 (CH3), 22.5 [CH(CH3)2],
55.7 (OCH3), 70.5 (ArCH2O)
a, 71.0 (OCH2CHCH2)
a, 75.1
[CH(CH3)2], 110.0 (CH), 116.9 (CH), 123.6 (C), 124.9 (CH), 125.0
(CH), 128.5 (C), 131.6 (CH), 135.0 (CH), 144.9 (C) and 152.7 (C);
MS m/z 276 (M+, 87%), 193 (100), 178 (38), 175 (63) and 161 (55);
HRMS calculated for C17H24O3: 276.1725, found: 276.1725.
6-Isopropoxy-7-methoxy-1,3-dihydro-2-benzoxepine . To
1-[(allyloxy)methyl]-3-isopropoxy-4-methoxy-2-(1-propenyl)
benzene 21 (0.12 g, 0.43 mmol) in toluene (12 cm3) was added to
Grubb’s catalyst 16 (5 mol %, 0.018 g, 0.02 mmol) and the reaction
mixture was stirred at 60°C for 2 h and then heated for another
2 h at 80°C. After removal of the solvent, the residue was purified
by silica gel chromatography (5–10% EtOAc-hexane) to give the
desired cyclized product 22 as a pale yellow oil (0.065 g, 64%),
starting material was also recovered (0.033 g, 28%). νmax
(film)/cm–1 (NaCl plate) 1598, 1578, 1487, 1434, 1402, 1380 and
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1342; 1H NMR (300 MHz; CDCl3) 1.29 [6H, d, J = 6.2 Hz,
CH(CH3)2], 3.82 (3H, s, OCH3), 4.39 [1H, sept, J = 6.2 Hz,
CH(CH3)2], 4.53–4.54 (2H, m, 3-H), 4.55 (2H, s, 1-H), 5.83–5.90
(1H, m, 4-H), 6.72 (1H, d, J = 8.2 Hz, 8-H), 6.83 (1H, d, J = 8.2 Hz,
9-H) and 6.90–6.96 (1H, m, 5-H); 13C NMR (75 MHz; CDCl3,
assignments with same superscript may be interchanged) 22.5
[CH(CH3)2], 55.8 (OCH3), 72.8 (3-C)
a, 73.0 (1-C)a, 75.7 [CH(CH3)2],
110.3 (CH), 122.3 (CH), 123.1 (CH), 123.5 (C), 132.2 (CH), 132.9
(C), 145.3 (C) and 152.7 (C); MS m/z 234 (M+, 81%), 192 (62), 177
(100) and 164 (38); HRMS calculated for C14H18O3: 234.1256,
found: 234.1256.
5-Isopropoxy-6-methoxy-1H-isochromene . To a degassed
solution of 2-allyl-1-[(allyloxy)methyl]-3-isopropoxy-4-
methoxybenzene 19 (0.10 g, 0.36 mmol) in toluene (20 cm3) was
added RuClH(CO)(PPh3)3 (1.5 mol %, 0.005 g, 0.005 mmol). The
mixture was heated at 60°C for 2 h under a N2 atmosphere. After-
wards Grubb’s catalyst 16 (5 mol %, 0.015 g, 0.018 mmol) was
added and the mixture was stirred for another 2 h at 60°C. After
cooling the mixture, the toluene was evaporated under reduced
pressure. The organic extract was then subjected to column
chromatography (5–20% EtOAc-hexane) to afford the desired
cyclized product 24 as a clear oil (0.066 g, 83%). νmax(film)/cm
–1
(NaCl plate) 1623, 1483, 1438 and 1382; 1H NMR (300 MHz,
CDCl3, assignments with same superscript may be inter-
changed) 1.28 [6H, d, J = 6.2 Hz, CH(CH3)2], 3.81 (3H, s, OCH3),
4.39 [1H, sept, J = 6.2 Hz, CH(CH3)2], 4.95 (2H, s, 1-H), 6.10 (1H, d,
J = 5.8 Hz, 4-H),a 6.58 (1H, d, J = 5.8 Hz, 3-H),a 6.67 (2H, br s, 7-H
and 8-H); 13C NMR (75 MHz, CDCl3) 22.5 [CH(CH3)2], 55.8
(OCH3), 67.7 (1-C), 75.2 [CH(CH3)2], 101.0 (CH), 109.0 (CH), 119.0
(CH), 121.5 (C), 125.2 (C), 140.4 (C), 145.9 (CH) and 152.8 (C); MS
m/z 220 (M+, 78%), 194 (54), 178 (83), 166 (86), 151 (91) and 150
(100); HRMS calculated for C13H16O3: 220.1099, found: 220.1098.
2-Allyl-3-isopropoxy-4-methoxyphenol . 35% H2O2 (1.8 cm
3)
was added dropwise to a cooled (ice bath) solution of 2-allyl-
3-isopropoxy-4-methoxybenzaldehyde 15 (2.0 g, 8.5 mmol) in
MeOH (22 cm3).18 To this solution was immediately added con-
centrated H2SO4 (3 drops) and the reaction mixture was allowed
to warm to r.t. The reaction mixture was stirred at this tempera-
ture until TLC confirmed that the aldehyde had been consumed
(1.5–2 h). The MeOH was removed under reduced pressure and
water (15 cm3) was then added to the resultant residue. The
aqueous layer was extracted with EtOAc (3 × 10 cm3), subse-
quently followed by washing of the organic phase with brine
solution (2 × 5 cm3) and drying (MgSO4). The solvent was
removed under vacuum and the resultant residue was then
purified by silica gel chromatography (10–15% EtOAc-hexane)
to give the desired product 25 as a pale yellow semi-solid (1.75 g,
93%). νmax (film)/cm
–1 (NaCl plate) 3354 br, 1501, 1459 and 1254;
1H NMR (300 MHz; CDCl3) 1.29 [6H, d, J = 6.2 Hz, CH(CH3)2], 3.52
(2H, br d, J = 6.0 Hz, CH2CHCH2), 3.78 (3H, s, OCH3), 4.48 [1H,
sept, J = 6.2 Hz, CH(CH3)2], 4.85 (1H, br s, OH, D2O exchange-
able), 5.13–5.19 (2H, m, CH2CHCH2), 5.92–6.05 (1H, m,
CH2CHCH2), 6.53 (1H, d, J = 8.8 Hz, 5-H) and 6.70 (1H, d, J =
8.8 Hz, 6-H); 13C NMR (75 MHz; CDCl3) 22.6 [CH(CH3)2], 29.0
(CH2CHCH2), 56.3 (OCH3), 74.8 [CH(CH3)2], 110.2 (CH), 111.5
(CH), 116.2 (CH), 120.4 (C), 136.3 (CH), 145.5 (C), 147.3 (C) and
149.2 (C); MS m/z 222 (M+, 52%), 180 (80), 165 (100), 137 (43) and
119 (16); HRMS calculated for C13H18O3: 222.1256, found:
222.1268.
2-Allyl-1-(allyloxy)-3-isopropoxy-4-methoxybenzene . Allyl
bromide (0.22 cm3, 2.5 mmol) and K2CO3 (0.35 g, 2.5 mmol) were
added to 2-allyl-3-isopropoxy-4-methoxyphenol 25 (0.28 g,
1.3 mmol) dissolved in acetone (10 cm3) and the reaction slurry
was then stirred at reflux for 2 h and then at r.t. for 48 h After
cooling, the excess K2CO3 was removed by filtration and the
solvent was removed under reduced pressure. The resultant
brown residue was then purified using silica gel column
chromatography (10–20% EtOAc-hexane) to afford compound
26 as a pale yellow oil (0.32 g, 97%). νmax (film)/cm
–1 (NaCl plate)
1558; 1H NMR (300 MHz; CDCl3) 1.19 [6H, d, J = 6.2 Hz,
CH(CH3)2], 3.39 (2H, br d, J = 6.2 Hz, ArCH2CHCH2), 3.70 (3H, s,
OCH3), 4.39 (2H, br d, J = 5.0 Hz, ArOCH2CHCH2), 4.45 [1H, sept,
J = 6.2 Hz, CH(CH3)2], 4.84–4.96 (2H, m, CH2CHCH2), 5.16 [1H,
dd, J = 10.6 and 1.5 Hz, CH2CHC(H)H], 5.30–5.36 [1H, m,
CH2CHC(H)H], 5.85–6.01 (2H, m, 2 × CH2CHCH2), 6.45 (1H, d,
J = 8.8 Hz, 5-H) and 6.60 (1H, d, J = 8.8 Hz, 6-H); 13C NMR
(75 MHz; CDCl3) 22.6 [CH(CH3)2], 28.9 (ArCH2CHCH2), 56.1
(OCH3), 69.4 (ArOCH2CHCH2), 74.6 [CH(CH3)2], 106.4 (CH),
110.0 (CH), 114.4 (CH), 116.6 (CH), 124.0 (C), 133.8 (CH), 136.9
(CH), 145.8 (C), 147.5 (C) and 151.4 (C); MS m/z 262 (M+, 53%), 220
(28), 179 (100), 147 (68), 73 (30) and 41 (24); HRMS calculated for
C16H22O3: 262.1569, found: 262.1589.
6-Isopropoxy-7-methoxy-2,5-dihydro-1-benzoxepine .
2-Allyl-1-(allyloxy)-3-isopropoxy-4-methoxybenzene 26 (0.10 g,
0.38 mmol) was dissolved in toluene (10 cm3) and Grubb’s cata-
lyst 16 (5 mol%, 0.016 g, 0.019 mmol) was added. The reaction
mixture was then stirred at 60°C for 13 h After removal of the sol-
vent under reduced pressure, the residue was purified by silica
gel chromatography (5–20% EtOAc-hexane) to give the desired
cyclized product 27 as a pale yellow oil (0.070 g, 80%). νmax
(film)/cm–1 (NaCl plate) 1672, 1569, 1481, 1377 and 1262; 1H NMR
(300 MHz; CDCl3) 1.26 [6H, d, J = 6.1 Hz, CH(CH3)2], 3.53–3.56
(2H, m, 5-H), 3.84 (3H, s, OCH3), 4.33 [1H, sept, J = 6.2 Hz,
CH(CH3)2], 4.51–4.55 (2H, m, 2-H), 5.40 (1H, br d, J = 11.4 Hz,
4-H), 5.78–5.84 (1H, m, 3-H), 6.67 (1H, d, J = 8.7 Hz, 5-H) and 6.77
(1H, d, J = 8.7 Hz, 6-H); 13C NMR (75 MHz; CDCl3) 22.5
[CH(CH3)2], 29.7 (5-C), 56.0 (OCH3), 71.9 (2-C), 75.2 [CH(CH3)2 ],
109.9 (CH), 115.7 (CH), 125.7 (CH), 127.7 (CH), 132.0 (C), 143.7
(C), 149.9 (C) and 152.9 (C); MS m/z 234 (M+, 37%), 206 (11), 192




26 (0.084 g, 0.36 mmol) and [RuClH(CO)(PPh3)3] 17 (0.015 g,
0.016 mmol, 5 mol %) were dissolved in distilled, degassed
toluene (5 cm3). The reaction was heated at 65°C for 14 h and
completion of the reaction was confirmed by NMR spectroscopy
of a crude sample. The reaction mixture was evaporated to
dryness and the resulting residue was purified by silica gel
chromatography (10–15% EtOAc-hexane) and evaporated
under reduce pressure to afford the product 28 (0.083 g, 99%) as a
mixture of E,Z isomers. νmax (film)/cm
–1 (NaCl plate) 1550 and
1475; 1H NMR (300 MHz; CDCl3) 1.26 [6H, d, J = 6.2 Hz,
CH(CH3)2], 1.72 (3H, dd, J = 6.2 and 1.4 Hz, CHCHCH3), 1.91 (3H,
d, J = 5.1 Hz, CHCHCH3), 3.79 (3H, s, OCH3), 4.41 [1H, sept, J =
6.2 Hz, CH(CH3)2], 4.75–4.80 (1H, m, CHCHCH3), 6.23–6.27 (1H,
m, CHCHCH3) and 6.54–6.68 (4H, m, 5-H, 6-H and 2 ×
CHCHCH3);
13C NMR (75 MHz; CDCl3) 9.4 (CHCHCH3), 20.0
(CHCHCH3), 22.5 [CH(CH3)2], 56.2 (OCH3), 75.3 [CH(CH3)2],
105.6 (CH), 110.2 (CH), 110.7 (CH), 122.1 (CH), 123.5 (CH), 131.6
(CH), 142.4 (CH), 145.5 (C), 149.0 (C) and 149.9 (C); MS m/z 262
(M+, 53%), 220 (16), 205 (27), 191 (100), 177 (18) and 164 (19);
HRMS calculated for C16H22O3: 262.1569, found: 262.1583.
4-Isopropoxy-5-methoxy-1-benzofuran . 2-Isopropoxy-1-
methoxy-3-(1-propenyl)-4-(1-propenyloxy)benzene 28 (0.061 g,
0.23 mmol) was dissolved in degassed toluene (5 cm3) and
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Grubb’s catalyst 16 (5 mol%, 0.0010 g, 0.0012 mmol) was added.
The reaction mixture was then stirred at 60°C for 3 h After
removal of the solvent under reduced pressure, the residue was
purified by silica gel chromatography (5–20% EtOAc-hexane) to
give the desired product 29 as a pale yellow oil (0.026 g, 55%).
The spectra obtained for compound 29 compared well with that
already published in the literature.20
3-Isopropoxy-4-methoxy-2-(1-propenyl)phenol . 2-Allyl-3-
isopropoxy-4-methoxyphenol 25 (1.0 g, 4.5 mmol) and
[RuClH(CO)(PPh3)3] 17 (0.22 g, 0.22 mmol, 5 mol %) were dis-
solved in distilled, degassed toluene (21 cm3). The reaction was
heated at 65°C for 23 h and the completion of the reaction
was confirmed by NMR spectroscopy of a crude sample. The
reaction mixture was evaporated to dryness and the resulting
residue was purified by silica gel chromatography (5–20%
EtOAc-hexane) and evaporated under reduce pressure to afford
the product 30 (0.94 g, 93%, E:Z 3:1). νmax (film)/cm
–1 (NaCl plate)
3300 (br), 1550, 1477 and 1377; 1H NMR (300 MHz; CDCl3, only
E-isomer listed) 1.25 [6H, d, J = 6.2 Hz, CH(CH3)2], 1.93 (3H, d, J =
6.2 Hz, CHCHCH3), 3.77 (3H, s, OCH3), 4.43 [1H, sept, J = 6.2 Hz,
CH(CH3)2], 5.30 (1H, br s, OH), 6.16–6.23 (1H, m, CHCHCH3) and
6.46–6.79 (3H, m, 2 × ArH and CHCHCH3);
13C NMR (75 MHz;
CDCl3, only E-isomer listed) 19.2 (CHCHCH3), 22.5 [CH(CH3)2],
56.5 (OCH3), 75.2 [CH(CH3)2], 109.6 (CH), 112.1 (CH), 120.4 (C),
124.0 (CH), 131.0 (CH), 145.3 (C), 146.8 (C) and 147.6 (C); MS m/z
222 (M+, 61%), 180 (100), 165 (93), 137 (53) and 87 (70); HRMS
calculated for C13H18O3: 222.1256, found: 222.1242.
1-(Allyloxy)-3-isopropoxy-4-methoxy-2-(1-propenyl)benzene
. Allyl bromide (0.33 cm3, 0.45 g, 3.8 mmol) and K2CO3 (0.51 g,
3.8 mmol) were added to 3-isopropoxy-4-methoxy-2-
(1-propenyl)phenol 30 (0.42 g, 1.8 mmol) dissolved in acetone
(10 cm3) and the reaction slurry was then stirred at reflux, under
an Ar atmosphere, for 20 h After cooling, the base was removed
by filtration through a pad of celite and the solvent was removed
under reduced pressure. The resultant brown residue was then
purified using silica gel column chromatography (10%
EtOAc-hexane) to afford compound 31 as a pale yellow oil
(0.37 g, 75%, E:Z 7:3). νmax (film)/cm
–1 (NaCl plate) 1650, 1479 and
1378; 1H NMR (300 MHz; CDCl3, only E-isomer listed) 1.20–1.27
[6H, m, CH(CH3)2], 1.90 (3H, d, J = 5.6 Hz, CHCHCH3), 3.78 (3H, s,
OCH3), 4.38–4.49 [3H, m, CH(CH3)2 and OCH2CHCH2], 5.24–5.28
(1H, m, CH2CHC(H)H), 5.37–5.43 (1H, m, CH2CHC(H)H),
5.83–6.31 (2H, m, CH2CHCH2 and CHCHCH3) and 6.53–6.68 (3H,
m, 2 × ArH and CHCHCH3);
13C NMR (75 MHz; CDCl3, Z-isomer
listed in brackets) (19.8), 19.9 (CHCHCH3), 22.5 [CH(CH3)2],
(56.1), 56.3 (OCH3), (69.7), 69.9 (OCH2), (75.1), 75.2 [CH(CH3)2],
(107.1), 107.3 (CH), 110.3, (110.6) (CH), (116.9), 117.0 (CH), 122.4,
(122.8) (CH), 129.1 (C), 131.1, (131.3) (CH), 133.8, (133.9) (CH),
145.7 (C), 147.9 (C), (150.6) and 151.1 (C); MS m/z 262 (M+, 66%),
220 (21), 205 (30), 191 (100), 179 (20), 177 (23), 164 (23) and 147 (89);
HRMS calculated for C16H22O3: 262.1569, found: 262.1570.
5-isopropoxy-6-methoxy-2H-chromene . 1-(Allyloxy)-3-
isopropoxy-4-methoxy-2-(1-propenyl)benzene 31 (0.31 g,
1.2 mmol) was dissolved in toluene (30 cm3) and Grubb’s catalyst
16 (5 mol %, 0.0050 g, 0.059 mmol) was added. The reaction mix-
ture was then stirred at 60°C for 2 h After removal of the solvent
under reduced pressure, the residue was purified by silica gel
chromatography (5% EtOAc-hexane) to give the desired prod-
uct 32 as a pale yellow oil (0.198 g, 76%). νmax (film)/cm
–1 (NaCl
plate) 1649, 1482 and 1379; 1H NMR (300 MHz; CDCl3) 1.27 [6H,
d, J = 6.2 Hz, CH(CH3)2], 3.77 (3H, s, OCH3), 4.44 [1H, sept, J =
6.2 Hz, CH(CH3)2], 4.68 (2H, dd, J = 3.6 and 1.8 Hz, 2-H), 5.79 (1H,
dt, J = 9.9 and 3.6 Hz, 3-H), 6.49 (1H, d, J = 8.8 Hz, 7-H), 6.66 (1H,
d, J = 8.8 Hz, 8-H) and 6.77 (1H, br d, J = 9.9 Hz, 4-H); 13C NMR
(75 MHz; CDCl3) 22.5 [CH(CH3)2], 56.4 (OCH3), 64.9 (2-C), 75.4
[CH(CH3)2], 109.9 (CH), 112.6 (CH), 118.0 (C), 120.5 (CH), 121.7
(CH), 142.9 (C), 147.4 (C) and 148.2 (C); MS m/z 220 (M+, 21%), 205
(30), 191(100), 179 (20), 164 (23) and 147 (89); HRMS calculated for
C13H16O3: 220.1099, found: 220.1101.
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